AA
47
4
EXPD
40
3
FDX
41
11
GD
44
2
KMB
34
6
AIV
51
4
USB
46
3
IVZ
52
6
BXP
49
2
CL
50
2
JPM
59
3
DRI
47
4
PEP
47
2
HP
41
5
AMGN
42
-5
BDX
41
3
XOM
42
2
LEN
53
3
V
56
2
AON
49
2
AA
47
4
EXPD
40
3
FDX
41
11
GD
44
2
KMB
34
6
AIV
51
4
USB
46
3
IVZ
52
6
BXP
49
2
CL
50
2
JPM
59
3
DRI
47
4
PEP
47
2
HP
41
5
AMGN
42
-5
BDX
41
3
XOM
42
2
LEN
53
3
V
56
2
AON
49
2
Financhill
Back

Moleculin Biotech Vs. Citius Pharmaceuticals Industry Stock Comparison

Sell
29

MBRX
Moleculin Biotech

Last Price:
2.34
Seasonality Move:
-2.49%
Sell
20

CTXR
Citius Pharmaceuticals

Last Price:
0.34
Seasonality Move:
14.95%
Sell
29
Moleculin Biotech (MBRX) is a Sell

Is Moleculin Biotech a Buy, Sell or Hold?

  • The current Moleculin Biotech [MBRX] share price is $2.44. The Score for MBRX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • MBRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
Citius Pharmaceuticals (CTXR) is a Sell

Is Citius Pharmaceuticals a Buy, Sell or Hold?

  • The current Citius Pharmaceuticals [CTXR] share price is $0.35. The Score for CTXR is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • CTXR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

MBRX Stock Price Chart

What is Moleculin Biotech's stock price today?

  • The Moleculin Biotech share price today is $2.44
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MBRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

CTXR Stock Price Chart

What is Citius Pharmaceuticals's stock price today?

  • The Citius Pharmaceuticals share price today is $0.35
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTXR is experiencing slight selling pressure.

MBRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 45.52 Sell
Chaikin Money Flow: 3384 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.41 - 2.61) Sell
Bollinger Bands (100): (2.24 - 3.54) Sell

CTXR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 36.17 Sell
Chaikin Money Flow: -34056 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.36 - 0.42) Sell
Bollinger Bands (100): (0.42 - 0.78) Sell

MBRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.54 Sell
20-day SMA: 2.51 Sell
50-day SMA: 2.5 Sell
200-day SMA: 4.57 Sell
8-day EMA: 2.51 Sell
20-day EMA: 2.52 Sell
50-day EMA: 2.61 Sell
200-day EMA: 4.52 Sell

CTXR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.37 Sell
20-day SMA: 0.37 Sell
50-day SMA: 0.47 Sell
200-day SMA: 0.66 Sell
8-day EMA: 0.36 Sell
20-day EMA: 0.39 Sell
50-day EMA: 0.46 Sell
200-day EMA: 0.65 Sell

Moleculin Biotech Earnings Growth & MBRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.06 per share, and an increase next year of $8.81 per share.

Citius Pharmaceuticals Earnings Growth & CTXR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and an increase next year of $0.33 per share.

Moleculin Biotech Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Citius Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):